SG11202103567RA - Methods of treatment of inflammatory conditions and associated infections - Google Patents
Methods of treatment of inflammatory conditions and associated infectionsInfo
- Publication number
- SG11202103567RA SG11202103567RA SG11202103567RA SG11202103567RA SG11202103567RA SG 11202103567R A SG11202103567R A SG 11202103567RA SG 11202103567R A SG11202103567R A SG 11202103567RA SG 11202103567R A SG11202103567R A SG 11202103567RA SG 11202103567R A SG11202103567R A SG 11202103567RA
- Authority
- SG
- Singapore
- Prior art keywords
- treatment
- methods
- inflammatory conditions
- associated infections
- infections
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Dermatology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Rheumatology (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Immunology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2018903823A AU2018903823A0 (en) | 2018-10-10 | Compositions and methods of treatment of conditions of the gastrointestinal tract | |
AU2018903822A AU2018903822A0 (en) | 2018-10-10 | Compositions and methods of treatment of inflammatory conditions and infections | |
AU2019901176A AU2019901176A0 (en) | 2019-04-05 | Compositions and methods of treatment of inflammatory conditions and associated infections | |
AU2019901175A AU2019901175A0 (en) | 2019-04-05 | Compositions and methods of treatment of conditions of the gastrointestinal tract | |
PCT/AU2019/051092 WO2020073088A1 (fr) | 2018-10-10 | 2019-10-10 | Procédés de traitement d'affections inflammatoires et d'infections associées |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11202103567RA true SG11202103567RA (en) | 2021-05-28 |
Family
ID=70163621
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11202103567RA SG11202103567RA (en) | 2018-10-10 | 2019-10-10 | Methods of treatment of inflammatory conditions and associated infections |
Country Status (8)
Country | Link |
---|---|
US (1) | US20210338749A1 (fr) |
EP (1) | EP3863656A4 (fr) |
JP (1) | JP2022504792A (fr) |
CN (1) | CN114206362A (fr) |
AU (1) | AU2019356524A1 (fr) |
CA (1) | CA3124725A1 (fr) |
SG (1) | SG11202103567RA (fr) |
WO (1) | WO2020073088A1 (fr) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2022115907A1 (fr) * | 2020-12-01 | 2022-06-09 | Servatus Ltd | Méthodes pour améliorer la qualité du sommeil |
JP2023553956A (ja) * | 2020-12-09 | 2023-12-26 | セルバトゥス リミテッド | 関節の炎症性障害のための併用療法 |
CA3225609A1 (fr) * | 2021-08-19 | 2023-02-23 | Societe Des Produits Nestle S.A. | Postbiotique |
WO2023021140A1 (fr) * | 2021-08-19 | 2023-02-23 | Société des Produits Nestlé S.A. | Postbiotique |
US20230141346A1 (en) * | 2021-11-05 | 2023-05-11 | Trillium Medical Products, LLC | Infused undergarment |
WO2023097375A1 (fr) * | 2021-12-02 | 2023-06-08 | Servatus Ltd | Méthodes de traitement de la constipation |
CN115725469B (zh) * | 2022-11-28 | 2024-05-14 | 广西大学 | 一株副干酪乳杆菌及其应用 |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1306716B1 (it) * | 1999-06-21 | 2001-10-02 | Mendes S U R L | Associazione di batteri lattici e suo uso per la prevenzione e/o iltrattamento terapeutico di infezioni e di stati infiammatori. |
US20040208863A1 (en) * | 2003-01-30 | 2004-10-21 | James Versalovic | Anti-inflammatory activity from lactic acid bacteria |
ITMI20032391A1 (it) * | 2003-12-05 | 2005-06-06 | Consiglio Nazionale Ricerche | Olive da mensa contenenti microrganismi probiotici. |
KR20150003908A (ko) * | 2007-07-03 | 2015-01-09 | 다누타 크루셰프스카 | 유기 바이오연료의 제조를 위한 알파케토글루타레이트의 용도 |
JP4876262B2 (ja) * | 2008-10-24 | 2012-02-15 | 防衛省技術研究本部長 | 抗炎症効果を有する新規植物性乳酸菌株、該菌株を用いた炎症性腸疾患又は慢性下痢症に対する予防及び治療剤、抑制剤並びに添加剤 |
AU2010339573B2 (en) * | 2009-12-31 | 2014-08-28 | Ira Milton Trachtman | Compositions and method for treatment and prophylaxis of inflammatory bowel disease |
US9492487B2 (en) * | 2010-02-01 | 2016-11-15 | Matthew Ryan Garner | Microbial product containing multiple microorganisms |
CA2833937C (fr) * | 2011-05-16 | 2022-04-05 | Organobalance Medical Ag | Souches de lactobacilles, compositions comprenant ces souches et utilisation des souches pour prevenir ou traiter des maladies provoqueespar le streptocoque pyogene |
CN105517557B (zh) * | 2013-04-23 | 2021-11-30 | 特雷根控股有限公司 | 具有抗微生物活性的细菌菌株以及包含所述菌株的生物控制组合物 |
ITMI20130793A1 (it) * | 2013-05-14 | 2014-11-15 | Probiotical Spa | Composizione comprendente batteri lattici per uso nel trattamento preventivo e/o curativo delle cistiti ricorrenti. |
KR20150023132A (ko) * | 2013-08-23 | 2015-03-05 | (주) 아이투비 | 아토피 피부용 조성물 |
CN104000184A (zh) * | 2013-12-09 | 2014-08-27 | 胡安然 | 一种调理萎缩性胃炎的膳食 |
WO2016179639A1 (fr) * | 2015-05-13 | 2016-11-17 | Markson Ro | Compositions probiotiques et leurs utilisations |
CN106860441B (zh) * | 2017-02-10 | 2019-12-31 | 中国医学科学院医药生物技术研究所 | 4-氧代-2-丁烯酰胺衍生物在制备抑菌剂中的应用 |
KR101917497B1 (ko) * | 2017-02-18 | 2018-11-09 | 박병희 | 신규한 락토바실러스 부크네리 및 이의 용도 |
TWI607758B (zh) * | 2017-03-07 | 2017-12-11 | 景岳生物科技股份有限公司 | 改善乾癬症狀的副乾酪乳桿菌菌株gmnl-653及其組合物 |
SG11201908857QA (en) * | 2017-04-11 | 2019-10-30 | Servatus Ltd | Methods for the treatment of inflammation and inflammatory conditions |
US11406672B2 (en) * | 2018-03-14 | 2022-08-09 | Sustainable Community Development, Llc | Probiotic composition and feed additive |
-
2019
- 2019-10-10 SG SG11202103567RA patent/SG11202103567RA/en unknown
- 2019-10-10 JP JP2021520168A patent/JP2022504792A/ja active Pending
- 2019-10-10 CN CN201980082026.6A patent/CN114206362A/zh active Pending
- 2019-10-10 WO PCT/AU2019/051092 patent/WO2020073088A1/fr unknown
- 2019-10-10 CA CA3124725A patent/CA3124725A1/fr active Pending
- 2019-10-10 US US17/284,207 patent/US20210338749A1/en active Pending
- 2019-10-10 EP EP19870476.9A patent/EP3863656A4/fr active Pending
- 2019-10-10 AU AU2019356524A patent/AU2019356524A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
CA3124725A1 (fr) | 2020-04-16 |
AU2019356524A1 (en) | 2021-05-13 |
WO2020073088A1 (fr) | 2020-04-16 |
US20210338749A1 (en) | 2021-11-04 |
JP2022504792A (ja) | 2022-01-13 |
EP3863656A1 (fr) | 2021-08-18 |
CN114206362A (zh) | 2022-03-18 |
EP3863656A4 (fr) | 2022-06-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SG11202103567RA (en) | Methods of treatment of inflammatory conditions and associated infections | |
EP3609515A4 (fr) | Procédés pour le traitement d'une inflammation et d'affections inflammatoires | |
IL281277A (en) | Preparations and methods for treating viral infections | |
ZA201801266B (en) | Composition and method for treatment and prophylaxis of intestinal infection and inflammation | |
GB201804514D0 (en) | Treatment of pyroptosis | |
EP3503903A4 (fr) | Traitement ascaroside de maladies auto-immunes et inflammatoires | |
IL272937A (en) | Preparations and methods for the treatment of diseases involving fibrosis | |
GB201804515D0 (en) | Treatment of necroptosis | |
SG11201809811VA (en) | Compositions and methods for treatment of inflammation or infection of the eye | |
IL281775A (en) | Methods of treating infections using bacteria | |
IL276053A (en) | Therapeutic Gard and methods of its use | |
IL260987A (en) | Treatment and diagnosis of inflammatory disorders | |
PT3708174T (pt) | Métodos e tratamento de trauma | |
SG11202003009QA (en) | Methods of treating bacterial infections | |
GB201810923D0 (en) | Compositions and method of treatment | |
EP3606516A4 (fr) | Méthode de traitement et de prévention d'infections | |
AU2018903822A0 (en) | Compositions and methods of treatment of inflammatory conditions and infections | |
GB201815000D0 (en) | Treatment of hypothroidism and related conditions | |
EP4003283C0 (fr) | Traitement d'affections cutanées inflammatoires | |
AU2019901176A0 (en) | Compositions and methods of treatment of inflammatory conditions and associated infections | |
HUE064198T2 (hu) | Tüdõgyulladás kezelése | |
GB201816914D0 (en) | Treatment of inflammation | |
GB201810925D0 (en) | Compositions and methods of treatment | |
AU2017902271A0 (en) | Methods for the treatment of inflammation and inflammatory conditions | |
EP3773328C0 (fr) | Syndrome de poland et méthodes de traitement |